From USFDA
Natco Pharma has received final approval for Abbreviated New Drug Application (ANDA) containing a paragraph IV certification filed with the United Food and Drug Administration for generic version of Armodafinil Tablets, 50 mg, 150 mg and 250 mg. The Company and its marketing partner Breckenridge Pharmaceutical, Inc. plant to launch this product in USA market immediately.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
